Materials Today Bio · 2023 · 12 citations · 28 references
PharmacyOncologyPharmacologyChemotherapyDrug DeliveryNanoparticle Drug DeliveryCancer NanomedicineNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignNanoparticle FormulationsAnticancer Drug LoadingCancer NanotherapyNanoparticle Cellular UptakeNanoparticle-based ChemotherapyNanoparticle-delivered ProdrugsOvarian Cancer ChemotherapyOvarian Cancer TreatmentPlatinum Compounds
Cisplatin is a metal platinum complex commonly used in the field of anti-tumor and one of the most commonly used drugs in combination chemotherapy. However, chemotherapy with Cisplatin induced overexpression of cyclooxygenase-2 (COX-2) protein in tumor cells, which could impair the therapeutic effect of chemotherapy on tumor progression. Here, we presented a novel method for the treatment of ovarian cancer with a self-assembly based nano-system. Cisplatin and tolfenamic acid were each linked to linoleic acid to give them the ability to self-assemble into nanoparticles in water. TPNPs had flexible drug ratio adjustability, homogeneous stability, and high drug loading capacity. Compared with Cisplatin, TPNPs could promote cellular uptake and tumor aggregation, co-induce enhanced apoptosis and tumor growth inhibition by inhibiting COX-2 in the mice xenograft model of human ovarian cancer, and reduce systemic toxicity. Therefore, TPNPs is a promising antitumor drug as a kind of self-assembly nano-prodrug with high drug load.
28
Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells
Juan Wang, Gen Sheng Wu · Journal of Biological Chemistry · 2014 · 295 citations · Full text
Medicine, Cell Biology, Oncology +17